SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Pieris Pharmaceuticals, Inc. - PIRS

Group 1 - Monteverde & Associates PC is investigating Pieris Pharmaceuticals, Inc. regarding its proposed merger with Palvella Therapeutics, Inc. [1] - Under the merger agreement, Pieris shareholders are expected to own approximately 18% of the combined company [1]. - Monteverde & Associates PC has been recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report [1]. Group 2 - Monteverde & Associates PC is a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court [2]. - The firm is headquartered in the Empire State Building in New York City [2]. - The firm emphasizes that no company, director, or officer is above the law [3].